Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Alferon N injection undergoes phase III in HCV

July 19, 1996

SmithKline Beecham's new Havrix formulation receives Canadian approval

July 19, 1996

Janssen describes agent for decreased intestinal motility

July 19, 1996

CJ-12954: Pfizer's anti-Helicobacter pylori compound

July 19, 1996

Clinical trials begin for chronic hepatitis C agent, Alferon N Injection

July 12, 1996

Lamivudine for treatment of hepatitis B covered under U.S. patent

July 12, 1996

Otsuka peptide IL-1 production inhibitors in pipeline

July 12, 1996

Novopharm favored in patent infringement suit with Glaxo Wellcome

July 12, 1996

Good phase I results reported for Campylobacter vaccine

July 5, 1996

Ketotifen shown effective in NSAID-induced ulcer model

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...